Clinical Trial Update: Cetuximab Monotherapy Maintenance Treatment in mCRC [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase 2/Phase 3 trial evaluating cetuximab as monotherapy maintenance treatment for metastatic colorectal cancer. The curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: UNKNOWN